Explore our news page for thought leadership articles, technical expertise and the latest developments in the world of innovation funding.
Filter
Discover how Myriad Associates played a pivotal role in securing grants for VERSONO Medical, revolutionising vascular healthcare. Explore our partnership and its impact.
Hooke Biotechnology have secured €5.5m in blended finance from the highly competitive Horizon Europe EIC Accelerator to develop Mera.
The Myriad R&D grants team is proud to have smashed our €100 million funding target. That's definitely something to shout about!
The good news is, there’s a huge scope of projects right across the medical industry that could make your company eligible for R&D Tax Credits. In fact, it’s one of the most lucrative.
Calls for Important Projects of Common European Interest (IPCEI) on Health is now OPEN!
In our quest to find out if women are still treated differently in the workplace, this is part 2 of our interview with two leading women in BioTech...
Are women still treated differently in the workplace? Is it harder for them to get to the top than men? I sat down with two leading women in BioTech to find out their thoughts...
Ireland is fast becoming the place to be for all things MedTech. How have they done it and what makes them one of the worlds leading MedTech hubs?
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF) for five, round 3 health and life science projects.
After an incredibly tough year filled with uncertainty and worry, Myriad Associates are pleased to welcome three new additions to the team!
Thanks to Mixed Reality, surgeons will also soon be able to perform operations with more accuracy and precision than ever before
Enterprise Ireland has recently reported that over one-hundred companies are coming up with innovative solutions in the fight against COVID-19.
With effective social distancing set to continue longer term, there’s a strong hope that COVID-19 will disappear and won’t be seen again. But with the possibility of a second wave come winter, the race for a vaccine is on.
Over the course of this year in particular, Irish pharmaceutical companies have been notably boosting investment in their research and development (R&D) activities
Tax Cloud, Myriad Associates’ online R&D tax relief claim portal has launched in Ireland this week to help Irish businesses benefit from the Revenue’s R&D tax credit entitlement.
6 months and one grant application later, Marc and the Myriad Associates grant bid writing team had secured a grant of €4.3m from the DTIF for Onkimmune and their consortium partners.
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
Revenue recognises many areas of the medical field as part of Medical Sciences. Most of which could make your company eligible for R&D tax credits.
The Myriad Associates team continues to grow from strength to strength, and we’re thrilled to introduce you to our newest team member.